Transchem Limited Submits Quarterly Compliance Certificate for Q4FY26

1 min read     Updated on 08 Apr 2026, 09:14 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Transchem Limited submitted its quarterly certificate under SEBI Depositories Regulation 74(5) for Q4FY26 quarter ended March 31, 2026. The certificate from MUFG Intime India Private Limited confirms compliance with dematerialisation requirements and proper processing of securities within prescribed timelines. The submission was made to BSE Limited on April 08, 2026, as part of regular regulatory compliance obligations.

powered bylight_fuzz_icon
37208691

*this image is generated using AI for illustrative purposes only.

Transchem Limited has submitted its quarterly compliance certificate to BSE Limited, fulfilling regulatory requirements under SEBI Depositories Regulations for the quarter ended March 31, 2026.

Regulatory Compliance Submission

The company filed the certificate under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018. The submission was made on April 08, 2026, to the Listing Compliance Department of BSE Limited.

Parameter Details
Quarter Ended March 31, 2026
Submission Date April 08, 2026
Regulation SEBI Depositories Regulation 74(5)
Exchange BSE Limited
Scrip Code 500422

Certificate Details

The certificate was issued by MUFG Intime India Private Limited, formerly known as Link Intime India Private Limited, which serves as the Registrar to an Issue and Share Transfer Agent for Transchem Limited. The certificate confirms that securities received from depository participants for dematerialisation during the quarter were properly processed and confirmed to the depositories within prescribed timelines.

MUFG Intime India confirmed that all security certificates received for dematerialisation were verified, mutilated, and cancelled after due verification by the depository participant. The company also confirmed that the names of the depositories have been substituted in the register of members as the registered owner within the prescribed timelines.

Corporate Information

Transchem Limited operates from its registered office at 111, Maker Chambers IV, 11th Floor, Nariman Point, Mumbai. The submission was signed by Neeraja Karandikar, Company Secretary (ACS - 10130), on behalf of the company. The certificate from MUFG Intime India was signed by Ashok Shetty, Sr. Vice President-Corporate Registry, and dated April 01, 2026.

This quarterly submission represents part of Transchem Limited's ongoing compliance with SEBI regulations governing depositories and participants, ensuring proper handling of securities dematerialisation processes.

Historical Stock Returns for Transchem

1 Day5 Days1 Month6 Months1 Year5 Years
0.0%+9.71%+0.03%+170.30%+356.78%+936.71%

Will Transchem Limited's consistent regulatory compliance improve its ESG ratings and attract institutional investors in the coming quarters?

How might MUFG Intime India's rebranding from Link Intime affect the quality of registrar services for Transchem's future corporate actions?

Could Transchem's strong compliance track record position it favorably for potential inclusion in SEBI's upcoming regulatory sandbox programs?

Transchem Limited Reports 62% Decline in Q3FY26 Net Profit to ₹52.94 Lakhs

2 min read     Updated on 07 Feb 2026, 02:29 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Transchem Limited reported Q3FY26 net profit of ₹52.94 lakhs, down 62% from ₹138.94 lakhs in Q3FY25, primarily due to increased expenses. Nine-month profit declined 51% to ₹220.19 lakhs. The company operates without operational revenue, relying on other income of ₹224.78 lakhs in Q3FY26. Shareholders approved warrant issuance of up to 6,15,00,000 units at ₹75 each, pending BSE approval.

powered bylight_fuzz_icon
32000392

*this image is generated using AI for illustrative purposes only.

Transchem Limited has reported a significant decline in profitability for the third quarter of fiscal year 2026, with net profit falling 62% year-on-year to ₹52.94 lakhs. The Mumbai-based company announced its unaudited financial results for the quarter ended December 31, 2025, during a board meeting held on February 7, 2026.

Financial Performance Overview

The company's financial performance showed mixed results across different metrics for Q3FY26:

Metric Q3FY26 Q3FY25 Change (%)
Total Income ₹224.78 lakhs ₹239.96 lakhs -6.33%
Other Income ₹224.78 lakhs ₹219.36 lakhs +2.47%
Total Expenses ₹130.96 lakhs ₹54.51 lakhs +140.25%
Net Profit ₹52.94 lakhs ₹138.94 lakhs -61.90%
Basic EPS ₹0.43 ₹1.13 -61.95%

Nine-Month Performance Analysis

For the nine-month period ended December 31, 2025, Transchem's performance continued to show declining trends compared to the previous year:

Parameter 9M FY26 9M FY25 Variance
Total Income ₹555.98 lakhs ₹717.68 lakhs -22.54%
Net Profit ₹220.19 lakhs ₹449.61 lakhs -51.02%
Basic EPS ₹1.80 ₹3.67 -50.95%

Expense Structure and Operations

The company's expense profile revealed significant changes during Q3FY26. Employee benefits expenses increased to ₹32.39 lakhs from ₹13.71 lakhs in the corresponding quarter of the previous year. Other expenses surged dramatically to ₹98.16 lakhs compared to ₹20.20 lakhs in Q3FY25, contributing to the overall decline in profitability.

Notably, Transchem Limited continues to operate without revenue from operations, with the company's income entirely derived from other sources. This operational structure has remained consistent across the reporting periods.

Corporate Developments

The company's shareholders approved a significant capital raising initiative during an Extraordinary General Meeting held on December 20, 2025. The approval covers the issuance of up to 6,15,00,000 warrants on a preferential basis at ₹75 per warrant. The company has applied to BSE Limited for in-principle approval for the proposed warrant allotment, which remains pending as of the reporting date.

Regulatory Compliance and Governance

The financial results were reviewed by the Audit Committee and approved by the Board of Directors. The statutory auditors, Mathur & Co., Chartered Accountants, conducted a limited review of the results without any qualifications. The company maintains compliance with Indian Accounting Standards and SEBI listing regulations.

Transchem Limited's paid-up equity share capital remains unchanged at ₹1,224.00 lakhs with a face value of ₹10 per share. The company operates as a single-segment entity with no reportable business or geographical segments under Indian Accounting Standard 108.

Historical Stock Returns for Transchem

1 Day5 Days1 Month6 Months1 Year5 Years
0.0%+9.71%+0.03%+170.30%+356.78%+936.71%

More News on Transchem

1 Year Returns:+356.78%